Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Toledo › NPI 1912954553
Hospital

Mercy Health - ST Anne Hospital LLC

Mercy Health - ST Anne Hospital LLC was paid $10.57M by Medicaid between Jan 2018 and Feb 2022, across 113 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.

33Billing provider infoMERCY HEALTH - ST ANNE HOSPITAL LLC
TOLEDO, OH 43623
33aNPI1912954553assigned 05/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.57M
24GClaims268,381
24DCodes billed113
24AFirst – last monthJan 2018 – Feb 2022
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#76 of 101
Median peer was paid$22.32M
This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201871,938$2.19M
201961,866$2.05M
202056,517$2.63M
202168,952$3.29M
20229,108$409K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 42% 38,323 36,340 $4.40M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 15,689 14,781 $1.95M
99282 Emergency department visit for the evaluation and management, low to moderate severity 15% 15,072 14,422 $1.57M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.2% 5,037 4,636 $758K
70450 Computed tomography, head or brain; without contrast material 4.1% 1,867 1,741 $437K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.6% 2,771 2,567 $377K
80048 Basic metabolic panel (calcium, ionized) 1.6% 17,879 15,847 $165K
64483 1.4% 342 289 $146K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 455 427 $123K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 453 434 $67K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,809 9,089 $56K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 325 301 $53K
101 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 273 $52K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,679 $30K
96361 Intravenous infusion, hydration; each additional hour <1% 178 $30K
80053 Comprehensive metabolic panel <1% 3,507 $30K
36415 Collection of venous blood by venipuncture <1% 18,293 $27K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 216 $23K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 48 $23K
84484 <1% 4,986 $22K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 28 $19K
77063 Screening digital breast tomosynthesis, bilateral <1% 567 $18K
71045 Radiologic examination, chest; single view <1% 5,125 $16K
80076 <1% 2,824 $15K
83874 <1% 1,574 $14K
96375 Therapeutic injection; each additional sequential IV push <1% 6,943 $12K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 43 $12K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 812 $11K
85027 <1% 2,026 $10K
64635 <1% 19 $10K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,636 $10K
64493 <1% 14 $8K
71046 Radiologic examination, chest; 2 views <1% 3,616 $7K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 277 $6K
83605 <1% 699 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,445 $6K
77067 Screening mammography, bilateral, including computer-aided detection <1% 589 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 263 $5K
82553 <1% 303 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 164 $3K
80061 Lipid panel <1% 219 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $3K
84443 Thyroid stimulating hormone (TSH) <1% 171 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 165 $3K
G0378 Hospital observation service, per hour <1% 60 $2K
87510 <1% 79 $2K
81001 <1% 6,996 $2K
85379 <1% 377 $2K
64636 <1% 19 $1K
84439 <1% 63 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,438 $1K
83690 <1% 4,417 $1K
84703 <1% 4,120 $1K
83880 <1% 225 $1K
82607 <1% 36 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,366 $1K
80320 <1% 51 $1K
87660 <1% 79 $933.76
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 812 $933.01
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 348 $920.55
83525 <1% 26 $844.77
81003 <1% 4,546 $715.55
81025 <1% 3,750 $622.72
82746 <1% 24 $507.68
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 3,436 $485.40
84436 <1% 25 $475.04
72125 Computed tomography, cervical spine; without contrast material <1% 25 $458.30
99152 <1% 1,354 $447.24
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,636 $425.97
83735 <1% 1,294 $372.19
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,078 $360.81
84481 <1% 13 $252.28
82150 <1% 581 $239.53
84480 <1% 25 $237.55
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,245 $237.30
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 538 $223.48
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,693 $220.42
74022 <1% 102 $188.79
73610 <1% 26 $110.37
99153 Mod sedat endo service >5yrs <1% 204 $88.68
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 15 $85.72
82550 <1% 305 $83.17
84134 <1% 15 $71.03
85610 <1% 142 $67.86
73130 <1% 111 $56.58
73562 <1% 56 $53.94
73630 <1% 114 $53.94
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,742 $49.32
J1170 Injection, hydromorphone, up to 4 mg <1% 264 $46.36
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 317 $29.42
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 368 $26.62
J2704 Injection, propofol, 10 mg <1% 847 $21.20
82947 <1% 91 $17.89
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 971 $14.00
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,546 $13.84
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 69 $10.34
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,945 $9.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,473 $8.81
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 243 $7.53
J8540 Dexamethasone, oral, 0.25 mg <1% 24 $6.30
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 102 $6.10
J2550 Injection, promethazine hcl, up to 50 mg <1% 143 $1.93
64484 0% 12 $0.00
96376 0% 90 $0.00
72040 0% 27 $0.00
87480 0% 79 $0.00
85730 0% 27 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 28 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 25 $0.00
72100 0% 198 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 78 $0.00
94664 0% 58 $0.00
01999 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBERTKE, BRAD (PRESIDENT & COO)